Which is better, Beijing Sinovac or Beijing Biovaccine? Detailed explanation of the advantages and disadvantages of Beijing Sinovac and Beijing Biovaccines

Today, the global epidemic is still spreading, and there are also outbreaks in some regions in China. In order to control the epidemic, all countries are developing new coronavirus vaccines. There are many kinds of vaccines on the market in China, of which Beijing Biotech and Beijing Sinovac are of great concern. So which is better, Beijing Sinovac or Beijing Sinovac? Detailed explanation of the advantages and disadvantages of Sinovac and Beijing Biovaccines. Interested friends can take a look together, hoping to be helpful to everyone.

Advantages and Disadvantages of Sinovac and Beijing Biological COVID-19 Vaccine

1. Advantages of Beijing Biological COVID-19 Vaccine [SEP]: It is produced by Sinopharm Group, and its quality is guaranteed. And three phases of clinical data have already been released. It is reported that this is the first phase III clinical trial result of the new inactivated coronary artery vaccine officially released in the world, and also the first release of the phase III clinical trial result of the new inactivated coronary artery vaccine in China. The Beijing biological vaccine produces antibodies 10 days after the first vaccination and high titer antibodies 14 days after two vaccinations, forming effective protection.

Disadvantages: Abnormal or adverse reactions may occur.

2. Advantages of Beijing Sinovac COVID-19 Vaccine [SEP]: Sinovac is an international vaccine and has received nearly 300 million orders. The protection rate reached 91.25%.

Disadvantages: Vaccination may have a few adverse reactions, such as redness, induration, pain, etc. But these adverse reactions do not require special treatment and can resolve on their own after 2-3 days.

Which is better, Beijing Sinovac or Beijing Biovaccine?

Beijing Biological Vaccine is the first approved inactivated novel coronavirus vaccine in China, which can produce antibodies 10 days after the first inoculation. After two injections, after 14 days, high titer antibodies can be produced, forming effective protection; The Beijing Sinovac vaccine has a very significant protective effect and has been proven to protect against variant strains in various countries.